(UROY) Uranium Royalty - Overview
Sector: EnergyIndustry: Uranium | Exchange NASDAQ (USA) | Currency USD | Market Cap: 482m | Total Return 84.5% in 12m
Stock: Uranium, Royalties, Physical, Mining
Total Rating 58
Risk 73
Buy Signal -1.15
| Risk 5d forecast | |
|---|---|
| Volatility | 62.5% |
| Relative Tail Risk | -10.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.13 |
| Alpha | 62.34 |
| Character TTM | |
|---|---|
| Beta | 1.746 |
| Beta Downside | 1.939 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.73% |
| CAGR/Max DD | 0.30 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 109.6667
Technicals: volatileDescription: UROY Uranium Royalty March 04, 2026
Uranium Royalty Corp. (NASDAQ: UROY) is a pure-play uranium royalty company. This business model provides exposure to uranium price movements without direct mining operational risks.
The company acquires and manages a portfolio of uranium royalties across Canada, the United States, Namibia, and Spain. Uranium royalties typically involve a right to a percentage of production or revenue from a mining operation.
In addition to royalties, UROY invests in uranium-exposed companies and physical uranium. Holding physical uranium provides direct exposure to the commoditys spot price.
Established in 2017 and headquartered in Vancouver, Canada, UROY operates within the Coal & Consumable Fuels GICS Sub-Industry. Further insights into UROYs valuation and performance can be found on ValueRay.
Headlines to watch out for
- Global uranium prices dictate royalty and physical uranium value
- New royalty acquisitions expand revenue base
- Regulatory changes impact uranium mining operations
- Geopolitical instability affects uranium supply and demand
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 4.39m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 26.86 > 1.0 |
| NWC/Revenue: 592.8% < 20% (prev 1.03k%; Δ -436.9% < -1%) |
| CFO/TA 0.11 > 3% & CFO 41.6m > Net Income 4.39m |
| Net Debt (-124.3m) to EBITDA (5.26m): -23.62 < 3 |
| Current Ratio: 325.3 > 1.5 & < 3 |
| Outstanding Shares: last quarter (142.1m) vs 12m ago 8.47% < -2% |
| Gross Margin: 17.72% > 18% (prev 0.31%; Δ 1.74k% > 0.5%) |
| Asset Turnover: 16.03% > 50% (prev 7.75%; Δ 8.28% > 0%) |
| Interest Coverage Ratio: 317.2 > 6 (EBITDA TTM 5.26m / Interest Expense TTM 16.0k) |
Altman Z'' 10.00
| A: 0.85 (Total Current Assets 324.8m - Total Current Liabilities 999k) / Total Assets 383.0m |
| B: 0.06 (Retained Earnings 22.8m / Total Assets 383.0m) |
| C: 0.01 (EBIT TTM 5.08m / Avg Total Assets 340.8m) |
| D: 272.2 (Book Value of Equity 381.6m / Total Liabilities 1.40m) |
| Altman-Z'' Score: 291.6 = AAA |
Beneish M -2.41
| DSRI: 0.01 (Receivables 8.01k/596k, Revenue 54.6m/23.1m) |
| GMI: 1.76 (GM 17.72% / 31.28%) |
| AQI: 0.77 (AQ_t 0.15 / AQ_t-1 0.20) |
| SGI: 2.36 (Revenue 54.6m / 23.1m) |
| TATA: -0.10 (NI 4.39m - CFO 41.6m) / TA 383.0m) |
| Beneish M-Score: -2.41 (Cap -4..+1) = BBB |
What is the price of UROY shares?
As of March 29, 2026, the stock is trading at USD 3.34 with a total of 2,907,178 shares traded.
Over the past week, the price has changed by +1.52%, over one month by -22.14%, over three months by -8.74% and over the past year by +84.53%.
Over the past week, the price has changed by +1.52%, over one month by -22.14%, over three months by -8.74% and over the past year by +84.53%.
Is UROY a buy, sell or hold?
Uranium Royalty has received a consensus analysts rating of 4.20.
Therefore, it is recommended to buy UROY.
- StrongBuy: 2
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the UROY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4.6 | 36.8% |
| Analysts Target Price | 4.6 | 36.8% |
UROY Fundamental Data Overview March 29, 2026
Market Cap CAD = 669.5m (481.9m USD * 1.3892 USD.CAD)
P/E Trailing = 109.6667
P/E Forward = 909.0909
P/S = 8.826
P/B = 1.7393
Revenue TTM = 54.6m CAD
EBIT TTM = 5.08m CAD
EBITDA TTM = 5.26m CAD
Long Term Debt = 168k CAD (from capitalLeaseObligations, last quarter)
Short Term Debt = 59.1k CAD (from shortTermDebt, last quarter)
Debt = 168k CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = -124.3m CAD (from netDebt column, last quarter)
Enterprise Value = 530.5m CAD (669.5m + Debt 168k - CCE 139.1m)
Interest Coverage Ratio = 317.2 (Ebit TTM 5.08m / Interest Expense TTM 16.0k)
EV/FCF = 13.08x (Enterprise Value 530.5m / FCF TTM 40.6m)
FCF Yield = 7.65% (FCF TTM 40.6m / Enterprise Value 530.5m)
FCF Margin = 74.28% (FCF TTM 40.6m / Revenue TTM 54.6m)
Net Margin = 8.03% (Net Income TTM 4.39m / Revenue TTM 54.6m)
Gross Margin = 17.72% ((Revenue TTM 54.6m - Cost of Revenue TTM 44.9m) / Revenue TTM)
Gross Margin QoQ = 25.10% (prev 29.27%)
Tobins Q-Ratio = 1.39 (Enterprise Value 530.5m / Total Assets 383.0m)
Interest Expense / Debt = 2.38% (Interest Expense 4.01k / Debt 168k)
Taxrate = 21.0% (US default 21%)
NOPAT = 4.01m (EBIT 5.08m * (1 - 21.00%))
Current Ratio = 325.3 (out of range, set to none) (Total Current Assets 324.8m / Total Current Liabilities 999k)
Debt / Equity = 0.00 (Debt 168k / totalStockholderEquity, last quarter 381.6m)
Debt / EBITDA = -23.62 (Net Debt -124.3m / EBITDA 5.26m)
Debt / FCF = -3.06 (Net Debt -124.3m / FCF TTM 40.6m)
Total Stockholder Equity = 326.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.29% (Net Income 4.39m / Total Assets 383.0m)
RoE = 1.35% (Net Income TTM 4.39m / Total Stockholder Equity 326.0m)
RoCE = 1.56% (EBIT 5.08m / Capital Employed (Equity 326.0m + L.T.Debt 168k))
RoIC = 1.23% (NOPAT 4.01m / Invested Capital 325.8m)
WACC = 12.12% (E(669.5m)/V(669.6m) * Re(12.12%) + D(168k)/V(669.6m) * Rd(2.38%) * (1-Tc(0.21)))
Discount Rate = 12.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.93%
[DCF] Terminal Value 54.55% ; FCFF base≈40.6m ; Y1≈26.6m ; Y5≈12.2m
[DCF] Fair Price = 1.82 (EV 142.4m - Net Debt -124.3m = Equity 266.7m / Shares 146.5m; r=12.12% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 36.23 | EPS CAGR: 19.34% | SUE: 1.50 | # QB: 3
Revenue Correlation: 33.98 | Revenue CAGR: 129.1% | SUE: N/A | # QB: 0
EPS next Year (2027-04-30): EPS=0.01 | Chg7d=+0.005 | Chg30d=+0.005 | Revisions Net=-1 | Growth EPS=-98.9% | Growth Revenue=-99.7%
P/E Trailing = 109.6667
P/E Forward = 909.0909
P/S = 8.826
P/B = 1.7393
Revenue TTM = 54.6m CAD
EBIT TTM = 5.08m CAD
EBITDA TTM = 5.26m CAD
Long Term Debt = 168k CAD (from capitalLeaseObligations, last quarter)
Short Term Debt = 59.1k CAD (from shortTermDebt, last quarter)
Debt = 168k CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = -124.3m CAD (from netDebt column, last quarter)
Enterprise Value = 530.5m CAD (669.5m + Debt 168k - CCE 139.1m)
Interest Coverage Ratio = 317.2 (Ebit TTM 5.08m / Interest Expense TTM 16.0k)
EV/FCF = 13.08x (Enterprise Value 530.5m / FCF TTM 40.6m)
FCF Yield = 7.65% (FCF TTM 40.6m / Enterprise Value 530.5m)
FCF Margin = 74.28% (FCF TTM 40.6m / Revenue TTM 54.6m)
Net Margin = 8.03% (Net Income TTM 4.39m / Revenue TTM 54.6m)
Gross Margin = 17.72% ((Revenue TTM 54.6m - Cost of Revenue TTM 44.9m) / Revenue TTM)
Gross Margin QoQ = 25.10% (prev 29.27%)
Tobins Q-Ratio = 1.39 (Enterprise Value 530.5m / Total Assets 383.0m)
Interest Expense / Debt = 2.38% (Interest Expense 4.01k / Debt 168k)
Taxrate = 21.0% (US default 21%)
NOPAT = 4.01m (EBIT 5.08m * (1 - 21.00%))
Current Ratio = 325.3 (out of range, set to none) (Total Current Assets 324.8m / Total Current Liabilities 999k)
Debt / Equity = 0.00 (Debt 168k / totalStockholderEquity, last quarter 381.6m)
Debt / EBITDA = -23.62 (Net Debt -124.3m / EBITDA 5.26m)
Debt / FCF = -3.06 (Net Debt -124.3m / FCF TTM 40.6m)
Total Stockholder Equity = 326.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.29% (Net Income 4.39m / Total Assets 383.0m)
RoE = 1.35% (Net Income TTM 4.39m / Total Stockholder Equity 326.0m)
RoCE = 1.56% (EBIT 5.08m / Capital Employed (Equity 326.0m + L.T.Debt 168k))
RoIC = 1.23% (NOPAT 4.01m / Invested Capital 325.8m)
WACC = 12.12% (E(669.5m)/V(669.6m) * Re(12.12%) + D(168k)/V(669.6m) * Rd(2.38%) * (1-Tc(0.21)))
Discount Rate = 12.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.93%
[DCF] Terminal Value 54.55% ; FCFF base≈40.6m ; Y1≈26.6m ; Y5≈12.2m
[DCF] Fair Price = 1.82 (EV 142.4m - Net Debt -124.3m = Equity 266.7m / Shares 146.5m; r=12.12% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 36.23 | EPS CAGR: 19.34% | SUE: 1.50 | # QB: 3
Revenue Correlation: 33.98 | Revenue CAGR: 129.1% | SUE: N/A | # QB: 0
EPS next Year (2027-04-30): EPS=0.01 | Chg7d=+0.005 | Chg30d=+0.005 | Revisions Net=-1 | Growth EPS=-98.9% | Growth Revenue=-99.7%